Search - tctmd.com

Displaying 1 - 20 of 236

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Daily News

Pain Sensitivity May Play Role in Unrecognized Myocardial Infarction

Leah Lawrence

December 27, 2016

News Daily News

High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds

Todd Neale

December 19, 2016

News Daily News

Not Following NOAC Dosing Instructions Tied to Worse Clinical Outcomes

Todd Neale

December 12, 2016

News Daily News

Prior Atherosclerosis Ups the Risk of Dying After Acute MI

Michael O'Riordan

December 09, 2016

News Daily News

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

Shelley Wood

December 02, 2016

News Daily News

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

L.A. McKeown

December 02, 2016

News Daily News

USPSTF: Counseling on Diet and Exercise Helpful but Not Mandatory for CVD Prevention

Caitlin E. Cox

December 02, 2016

News Daily News

PCSK9 Variants Linked With Lower LDL Cholesterol, Increased Diabetes Risk

Michael O'Riordan

December 01, 2016

News Daily News

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

L.A. McKeown

December 01, 2016

News Daily News

Lipid Losses: National Data Show Drastic Drops in Total Cholesterol, Triglycerides, and LDL

Yael L. Maxwell

November 30, 2016

News Conference News AHA 2016

Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention

Yael L. Maxwell

November 29, 2016

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

Michael O'Riordan

November 22, 2016

News Conference News AHA 2016

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

L.A. McKeown

November 17, 2016

News Conference News AHA 2016

Proton Pump Inhibitor Use Tied to Elevated Ischemic Stroke Risk

Todd Neale

November 16, 2016

News Conference News AHA 2016

Racial Differences in How Patients Perceive CVD Risk Should Spur Rethink in Management

Yael L. Maxwell

November 16, 2016

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

News Conference News AHA 2016

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

Michael O'Riordan

November 13, 2016

News Conference News AHA 2016

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Shelley Wood

November 13, 2016

Advertisement

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Pain Sensitivity May Play Role in Unrecognized Myocardial Infarction

High-Sensitivity Troponin Assays May Help With Response to Statins and Other Meds

Not Following NOAC Dosing Instructions Tied to Worse Clinical Outcomes

Prior Atherosclerosis Ups the Risk of Dying After Acute MI

FDA Approves CV Death Reduction Claim for Empagliflozin in Type 2 Diabetes

Smoking and Acute MI: The Younger the Patient, the Higher the Risk

USPSTF: Counseling on Diet and Exercise Helpful but Not Mandatory for CVD Prevention

PCSK9 Variants Linked With Lower LDL Cholesterol, Increased Diabetes Risk

Benefits of PCI for STEMI Not Attenuated in Patients With a Cancer History

Lipid Losses: National Data Show Drastic Drops in Total Cholesterol, Triglycerides, and LDL

Amid Rising Tide of Atherosclerotic CVD, Costs of Treatment Should Spur Policy Makers to Push Prevention

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Statin-Associated Muscle Pain? It May Be Your Genes, Says GAUSS-3 Analysis

Impaired Coronary Flow Reserve May Represent Hidden Biological Risk for Women

Proton Pump Inhibitor Use Tied to Elevated Ischemic Stroke Risk

Racial Differences in How Patients Perceive CVD Risk Should Spur Rethink in Management

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Secondhand Smoke Exposure Associated With Increased Risk of Coronary Atherosclerosis

No CV Safety Differences for COX-2 Inhibitor vs Other NSAIDs in PRECISION

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content